Literature DB >> 23583495

Interdependency of protein-release completeness and polymer degradation in PLGA-based implants.

Zahra Ghalanbor1, Martin Körber, Roland Bodmeier.   

Abstract

Release of BSA (model protein) from hot-melt extruded poly(lactide-co-glycolide) (PLGA)-based implants was incomplete. A residual mass of covalent BSA-PLGA adducts was still present after 6 months. The objective of this study was to increase the completeness of BSA release. BSA reduced the PLGA degradation and erosion rate as well as the extent of erosion. An increased uptake of release medium in the presence of BSA in addition to the early outflux of PLGA oligomers resulted in a reduction of the matrix acidity and thus reduction of autocatalysis effects. PLGA mass loss was incomplete at 60% and 80% for 10% and 25% BSA-containing implants. The extent of PLGA mass loss was correlated with the total releasable protein. The same release was obtained from implants prepared with pre-degraded PLGA suggesting that the induction phase did not affect the release completeness. Thus, the focus was on the erosion phase to enhance outflux of soluble oligomers. BSA release completeness increased by increasing the porosity of the implants at the onset of erosion phase. This could be obtained with a higher initial porosity, formation of porosity upon higher diffusional release and/or incorporation of pore-formers/plasticizers. Accordingly, the BSA release completeness could be improved by enhancing the outflux of soluble PLGA degradation products.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BSA; Biodegradation; Drug release; Erosion; Extrusion; Implant; Poly(lactide-co-glycolide); Protein

Mesh:

Substances:

Year:  2013        PMID: 23583495     DOI: 10.1016/j.ejpb.2013.03.031

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Milling solid proteins to enhance activity after melt-encapsulation.

Authors:  Parker W Lee; João Maia; Jonathan K Pokorski
Journal:  Int J Pharm       Date:  2017-09-20       Impact factor: 5.875

2.  Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.

Authors:  Parker W Lee; Sourabh Shukla; Jaqueline D Wallat; Chaitanya Danda; Nicole F Steinmetz; Joao Maia; Jonathan K Pokorski
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

3.  How bulk fluid renewal can affect in vitro drug release from PLGA implants: Importance of the experimental set-up.

Authors:  C Bassand; L Benabed; J Freitag; J Verin; F Siepmann; J Siepmann
Journal:  Int J Pharm X       Date:  2022-09-19

4.  Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study.

Authors:  Max Beugeling; Katie Amssoms; Freek Cox; Ben De Clerck; Ellen Van Gulck; Jeroen A Verwoerd; Guenter Kraus; Dirk Roymans; Lieven Baert; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Pharmaceutics       Date:  2019-10-03       Impact factor: 6.321

Review 5.  Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development.

Authors:  Yi Wen Lim; Wen Siang Tan; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Noor Hayaty Abu Kasim; Noorsaadah Abd Rahman; Tin Wui Wong; Chin Fei Chee
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.